MSB 2.08% 94.0¢ mesoblast limited

Ann: Jane Bell Appointed Chair of Audit and Risk Committee, page-34

  1. 16,945 Posts.
    lightbulb Created with Sketch. 2409
    "The FDA now deem our product Safe and Effective."

    If that was true then the FDA would have approved Remestemcel already.
    Instead they have twice rejected it and issued BLAs in response to the submissions.
    So clearly that statement must be false.
    That simple.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.0¢
Change
-0.020(2.08%)
Mkt cap ! $1.073B
Open High Low Value Volume
95.5¢ 97.0¢ 93.5¢ $1.424M 1.507M

Buyers (Bids)

No. Vol. Price($)
8 29390 93.5¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 14089 2
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.